Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Jason Bednar
PIPR
Jason Bednar
Wall Street Analyst
★★★☆☆
#1721
on 13Foresight · ranked by our own returns
46%
Success Rate
-2.1%
Average Return
13 of 28 calls profitable · -6.7% vs benchmark
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 46% of Jason Bednar's ratings turned a profit when each position was held for 1 year — averaging -2.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

99 Buy 35 Hold 0 Sell
Jason's Stock Coverage 24 ratings · 2026-06-19
Company Date Position Consensus Price Target 1-Yr Return
ALGN
Align Tech
Jun 18, 2026 BUY Strong Buy
+58.0% avg upside
21 analysts
$235.00
29.09% Upside
·
SOLV
Solventum Corporation
Jun 10, 2026 BUY Buy
+14.3% avg upside
15 analysts
$92.00
21.88% Upside
-7.9%
SHC
Sotera Health
Jun 10, 2026 BUY Strong Buy
+30.3% avg upside
13 analysts
$22.00
39.05% Upside
-3.0%
HSIC
Henry Schein
Jun 10, 2026 BUY Buy
+7.4% avg upside
25 analysts
$91.00
13.96% Upside
+3.0%
MMSI
Merit Medical Systems
Jun 10, 2026 BUY Strong Buy
+36.1% avg upside
15 analysts
$96.00
42.76% Upside
·
ICUI
ICU Medical
Jun 10, 2026 BUY Strong Buy
+15.2% avg upside
9 analysts
$163.00
16.11% Upside
·
TFX
Teleflex
Jun 08, 2026 BUY Buy
+42.3% avg upside
19 analysts
$160.00
25.89% Upside
-3.6%
COO
Cooper Co
Jun 05, 2026 BUY Buy
+102.5% avg upside
21 analysts
$86.00
30.46% Upside
+0.0%
BDX
Becton Dickinson
May 27, 2026 HOLD Buy
+35.6% avg upside
25 analysts
$161.00
11.87% Upside
-1.5%
NVCR
NovoCure
May 26, 2026 BUY Strong Buy
+242.2% avg upside
11 analysts
$27.00
89.15% Upside
·
DRTS
Alpha Tau Medical Ltd
May 19, 2026 HOLD Strong Buy
+41.1% avg upside
5 analysts
$8.00
18.13% Downside
-12.1%
STE
Steris
May 12, 2026 BUY Strong Buy
+22.1% avg upside
10 analysts
$300.00
47.97% Upside
-1.3%
NVST
Envista Holdings
May 07, 2026 HOLD Buy
+13.6% avg upside
19 analysts
$25.00
3.48% Downside
-4.4%
KRMD
REPRO-MED Systems
May 07, 2026 HOLD Strong Buy
+64.8% avg upside
9 analysts
$5.00
28.17% Upside
-6.8%
XRAY
DENTSPLY SIRONA
May 06, 2026 HOLD Buy
+171.7% avg upside
25 analysts
$13.00
25.77% Upside
-5.1%
MDLN
Medline
May 04, 2026 BUY Strong Buy
+42.9% avg upside
26 analysts
$55.00
53.01% Upside
-18.7%
LUNG
Pulmonx
Apr 30, 2026 HOLD Buy
+320.9% avg upside
9 analysts
$2.50
95.27% Upside
+7.0%
GEHC
GE Healthcare Technologies Inc
Apr 17, 2026 BUY Strong Buy
+36.1% avg upside
20 analysts
$88.00
42.86% Upside
-17.5%
FOCL
EDAP TMS
Jan 20, 2026 HOLD Buy
+43.2% avg upside
7 analysts
$2.50
48.08% Downside
·
XAIR
Beyond Air
Aug 13, 2025 BUY Strong Buy
+5809.0% avg upside
10 analysts
$5.00
1288.99% Upside
-79.6%
MDXH
MDxHealth
May 15, 2025 BUY Strong Buy
+1066.0% avg upside
8 analysts
$6.00
1005.03% Upside
-53.0%
SONX
Sonendo
Nov 09, 2023 HOLD Buy
+1875.0% avg upside
5 analysts
$0.40
33.36% Downside
·
VRAYQ
Viewray
Apr 24, 2023 BUY Strong Buy
+558333233.4% avg upside
12 analysts
$2.00
199999899.99% Upside
·
GE
GE Aerospace
Apr 19, 2023 BUY Strong Buy
-35.7% avg upside
49 analysts
$95.00
73.50% Downside
+88.1%
🔒 19 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Jason Bednar — Frequently Asked Questions
How accurate are Jason Bednar's stock ratings?
Based on the calls 13Foresight could measure, about 46% of Jason's ratings were profitable over a one-year hold, with an average return of -2.1% per rating, or -6.7% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Jason ranked on 13Foresight?
Jason Bednar is currently ranked #1721 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Jason cover?
Jason most recently has ratings on ALGN, SOLV, SHC, HSIC, MMSI, ICUI, TFX, COO, BDX, NVCR, DRTS, STE and 12 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.